Absci Investor Presentation Deck

て BOXER AMAS Absci is the first to design and validate novel antibodies using zero-shot generative Al Zero-shot: a machine learning technique in which a model is trained to recognize and classify new objects without explicitly being trained on those objects' examples. For antibodies, this means designing an antibody to bind to an antigen with no previous demonstrations of binders to said antigen. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED absci. 11

View entire presentation